Accelerating Drug Development by Reinventing the How

N-Power Medicine is building the first always-on clinical research system in community oncology to dramatically boost clinical trial participation and realize the promise of prospective external controls to accelerate and de-risk oncology R&D.

Company History

  • AUG 2021

    Founded by pharma drug development executives

  • AUG 2022

    Kaleido Registry Launched

  • JUNE 2024

    Established strategic partnership and investment from Merck & Merck Global Health Innovation Fund

  • JAN 2025

    Completed acquisition of Syapse Holdings, Inc.establishing N-Power as one of the largest community-based prospective clinical research networks

  • MAY 2025

    Launch First Prospective External Control

  • Raised $85M+ to Date from Leading US healthcare Investors

The Leadership Team

Bringing decades of combined experience in clinical research, technology, and healthcare to the company. Each member plays a crucial role in driving innovation and advancing our mission to transform clinical trials.

  • Mark Lee, MD, PhD

    Mark Lee, MD, PhD

    Chief Executive Officer and Co-Founder

    LinkedIn
  • Michael Seiden, MD

    Michael Seiden, MD

    Chief Medical Officer

    LinkedIn
  • Joel Smith

    Joel Smith

    Chief Financial Officer

    LinkedIn
  • Dennis Cieri

    Dennis Cieri

    Head of Software

    LinkedIn
  • Emily Luvison

    Emily Luvison

    Head, Security, Privacy, Quality & Compliance

    LinkedIn
  • Christer Svedman, MD, PhD

    Christer Svedman, MD, PhD

    Head of Clinical Science and Co-Founder

    LinkedIn
  • Thomas Bengtsson, PhD

    Thomas Bengtsson, PhD

    Head, Data and Technology

    LinkedIn
  • Luke Peterson

    Luke Peterson

    Head, Network Business Development

    LinkedIn
  • Maria Ferrari

    Maria Ferrari

    Head of Investor Relations & Chief of Staff

    LinkedIn
  • Jess Sinir

    Jess Sinir

    Head of Program Management

    LinkedIn
  • Will Chen

    Will Chen

    Senior Director, Pharma Alliance Management

    LinkedIn
  • Sydnie Reed

    Sydnie Reed

    Senior Director, Pharma Partnering and Portfolio Management

    LinkedIn
  • Ruchika Kumar

    Ruchika Kumar

    General Counsel and Head of People

    LinkedIn

N-Power Medicine Strategic Advisory Board

Our advisory board consists of industry and academic leaders specializing in Oncology, EMR technology, RWD, and more. Together they help us not only inform our company vision, but ensure we maintain focus on this mission of facilitating clinical trials and accelerating drug development.

  • Alan Sandler, MD

    Alan Sandler, MD

    Internationally Renowned Leader in Oncology and Drug Development

    LinkedIn
  • Andrea Ferris

    Andrea Ferris

    CEO LUNGevity Foundation

    LinkedIn
  • Barbara McAneny, MD, MACP, FASCO

    Barbara McAneny, MD, MACP, FASCO

    Founder, National Cancer Care Alliance; CEO, New Mexico Cancer Center

    LinkedIn
  • Bradley Malin, PhD

    Bradley Malin, PhD

    Accenture Professor of Biomedical Informatics, Biostatistics, & Computer ScienceVanderbilt University Medical Center

    LinkedIn
  • Christopher Flowers, MD, MSc

    Christopher Flowers, MD, MSc

    Chair and Professor at The University of TexasM.D. Anderson Cancer Center

    LinkedIn
  • Ethan Basch, MD, MSc

    Ethan Basch, MD, MSc

    Chief of Oncology UNC Chapel Hill School of Medicine

    LinkedIn
  • Fabrice André, MD, PhD

    Fabrice André, MD, PhD

    ESMO President-Elect Institut Gustave RoussyDepartment of Medical Oncology

    LinkedIn
  • Jeff Allen, PhD

    Jeff Allen, PhD

    President & CEO Friends of Cancer Research

    LinkedIn
  • Steven Shak, MD

    Steven Shak, MD

    Chief Medical Officer Genomic Life

    LinkedIn